NCT04450147

Brief Summary

It is expected that by 2030, the percentage of patients with bipolar disorder (BD) in Canada over 60 years of age will exceed 50%. In this population, poor cognition and persistent sub-threshold depressive symptoms are particularly common, difficult to treat, associated with increased mood episodes, and poor daily functioning. Mind-body interventions have increasingly been found to be effective in treating several psychiatric condition including BD. A few pilot studies examining mindfulness-based intervention in younger adult BD have been promising for depressive symptoms, but some pilot research suggest that patients with older age bipolar disorder (OABD) may benefit more from moving mindfulness. The investigators will conduct a 12-week randomized controlled trial to assess whether tai-chi/qigong will be associated with 1) greater reduction in depressive symptoms, and 2) greater improved cognition, in comparison to a light exercise active control condition, 12- and 24-weeks from baseline, in BD patients aged 40+.

Trial Health

87
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
23

participants targeted

Target at below P25 for not_applicable

Timeline
Completed

Started Nov 2020

Shorter than P25 for not_applicable

Geographic Reach
1 country

1 active site

Status
completed

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

First Submitted

Initial submission to the registry

March 3, 2020

Completed
4 months until next milestone

First Posted

Study publicly available on registry

June 29, 2020

Completed
4 months until next milestone

Study Start

First participant enrolled

November 10, 2020

Completed
3 months until next milestone

Primary Completion

Last participant's last visit for primary outcome

February 1, 2021

Completed
3 months until next milestone

Study Completion

Last participant's last visit for all outcomes

May 1, 2021

Completed
Last Updated

May 25, 2025

Status Verified

November 1, 2020

Enrollment Period

3 months

First QC Date

March 3, 2020

Last Update Submit

May 21, 2025

Conditions

Keywords

mindfulnessolder age bipolar disordertai chiqigongrandomized controlled trial

Outcome Measures

Primary Outcomes (1)

  • Change in Depression

    Level of depression as measured by the Montgomery-Asberg Depression Rating Scale, at 12-weeks and 24-weeks post-intervention. Possible score range: 0-60, higher score indicates worse outcome

    Baseline, 12-weeks, 24-weeks

Secondary Outcomes (1)

  • Change in Processing Speed

    Baseline, 12-weeks, 24-weeks

Other Outcomes (8)

  • Change in Quality of Life

    Baseline, 12-weeks, 24-weeks

  • Change in Daily Functioning

    Baseline, 12-weeks, 24-weeks

  • Change in Generalized Anxiety

    Baseline, 12-weeks, 24-weeks

  • +5 more other outcomes

Study Arms (2)

Tai Chi and Qigong

EXPERIMENTAL

50mins x 12 weeks of virtually-delivered group tai chi/qigong

Behavioral: Tai Chi/Qigong vs. Walking/Stretching

Walking and Stretching

ACTIVE COMPARATOR

50mins x 12 weeks of virtually-delivered group walking and stretching

Behavioral: Tai Chi/Qigong vs. Walking/Stretching

Interventions

Both interventions can be thought of as a form of movement and exercise.

Tai Chi and QigongWalking and Stretching

Eligibility Criteria

Age40 Years+
Sexall
Healthy VolunteersNo
Age GroupsAdult (18-64), Older Adult (65+)

You may qualify if:

  • aged greater than or equal to 40 years
  • history of diagnosis of bipolar I or II disorder
  • access to a computer with a functioning camera, microphone, and ability to run Zoom software
  • English or French speaking
  • ability to give informed consent

You may not qualify if:

  • Young Mania Rating Scale score \> 5
  • current clinician diagnosis of substance abuse, unless currently in complete remission
  • risk of suicide as assessed by a score above 3 on item 10 of Montgomery Asberg Depression Rating Scale
  • participation or plan to participate in any other concurrent psychosocial group program during course of study
  • unstable psychiatric medication (less than 4-weeks since commencement)

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

Lady Davis Institute

Montreal, Canada

Location

Related Publications (1)

  • Sajatovic M, Eyler LT, Rej S, Almeida OP, Blumberg HP, Forester BP, Forlenza OV, Gildengers A, Mulsant BH, Strejilevich S, Tsai S, Vieta E, Young RC, Dols A. The Global Aging & Geriatric Experiments in Bipolar Disorder Database (GAGE-BD) project: Understanding older-age bipolar disorder by combining multiple datasets. Bipolar Disord. 2019 Nov;21(7):642-649. doi: 10.1111/bdi.12795. Epub 2019 May 30.

    PMID: 31081573BACKGROUND

Related Links

MeSH Terms

Conditions

Bipolar Disorder

Condition Hierarchy (Ancestors)

Bipolar and Related DisordersMood DisordersMental Disorders

Study Design

Study Type
interventional
Phase
not applicable
Allocation
RANDOMIZED
Masking
TRIPLE
Who Masked
PARTICIPANT, INVESTIGATOR, OUTCOMES ASSESSOR
Purpose
TREATMENT
Intervention Model
PARALLEL
Sponsor Type
OTHER
Responsible Party
PRINCIPAL INVESTIGATOR
PI Title
Geriatric Psychiatrist, Assistant Professor, Principle Investigator

Study Record Dates

First Submitted

March 3, 2020

First Posted

June 29, 2020

Study Start

November 10, 2020

Primary Completion

February 1, 2021

Study Completion

May 1, 2021

Last Updated

May 25, 2025

Record last verified: 2020-11

Data Sharing

IPD Sharing
Will share

Data from the study will be sent to the Global Aging \& Geriatric Experiments in Bipolar Disorder Database (GAGE-BD). The objective of GAGE-BD is to gather data from research studies about older adults (age 50+) with bipolar disorder to allow researchers from the Douglas Institute, or other researchers, in Canada, the United States and around the world, to use the database for future research projects exploring possible relationships between age, medical conditions and bipolar symptoms. Following completion of data collection, the data including all outcomes and demographic and health information, anonymized and free of any identifying or personal information, will be sent to Dr. Betsy Wilson (more info on Dr. Wilson further below) via Box (https://case.edu/utech/help/knowledge-base/box/box-information), a secure cloud storage service managed by Case Western University.

Shared Documents
STUDY PROTOCOL, SAP, CSR
Time Frame
The data will be available June 2021 (anticipated), and will be kept at GAGE-BD indefinitely.
Access Criteria
All researcher-users involved in GAGE-BD agree not to communicate or transfer data to anyone. They agree not to use the data for a research study that is not approved by the GAGE-BD management or a Research Ethics Board.

Locations